Photodynamic therapy of choroidal melanoma

International Ophthalmology Clinics

Volumn 37, Issue 4, 1997, Pages 117-126

  Foster, Bradley S ^a   Gragoudas, Evangelos S ^a   Young, Lucy H Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SULFONATED PHTHALOCYANIN; BENZOPORPHYRIN DERIVATIVE; BIS SILICON 1,3 NAPHTHALOCYANINE; LIPOSOME; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARGON LASER; CANCER RADIOTHERAPY; CHOROID MELANOMA; CRYOTHERAPY; DIATHERMY; ENUCLEATION; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIC THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION INJURY; REVIEW;

ANIMALS; CHOROID NEOPLASMS; DRUG ADMINISTRATION ROUTES; HUMANS; MELANOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SAFETY; TREATMENT OUTCOME;

EID: 0031471715     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199703740-00010     Document Type: Review

References (86)

1. Cutler SJ, Young JL. Third national cancer survey: incidence data. Natl Cancer Inst Mongr 1975; 41:1-454.
2. Scotto J, Fraumeni JF, Lee JAH. Melanomas of the eye and other noncutaneous sites: epidemiological aspects. J Natl Cancer Inst 1976;56:489-491
3. Wilkes SR, Robertson DM, Kurland LT, Campbell RJ. Incidence of uveal melanoma in the resident population of Rochester and Olmstead County, Minnesota. Am J Ophthalmol 1979;87:639-641
4. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-251
5. Jensen OA. Malignant melanomas of the uvea in Denmark 1943-1952. A clinical, histopathological, and prognostic study. Acta Ophthalmol Suppl 1963;75:1-220
6. McLean IW, Foster WD, Zimmermann LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977;95:48-58
7. Shammus HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-69
8. Gragoudas ES, Seddon JM, Egan KM, et al. Prognostic factors for metastasis following proton beam irradiation. Ophthalmology 1986;93:675-680
9. Dunphy EB, Forest AW, Leopold IH, et al. Symposium on the diagnosis and management of intraocular melanomas. Trans Am Acad Ophthalmol Otolaryngol 1958;62: 517-555
10. DePotter P, Shields CL, Shields JA. New treatment modalities for uveal melanoma. Curr Opin Ophthalmol 1996;7:27-32
11. Gragoudas ES, Egan KM. Management of choroidal and ciliary body melanomas. Semin Ophthalmol 1993;8:224-229
12. Straatsma BR, Fine SL, Earle JD. The Collaborative Ocular Melanoma Study Research Group: enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988;95:1000-1004
13. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979;87:741-760
14. Moore RF. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 1930;14:145-152
15. Stallard HB. Radiotherapy of malignant intraocular neoplasm. Br J Ophthalmol 1948; 32:618-639
16. Cruess AF, Augsberger JJ, Shields JA. Visual results following cobalt plaque radiotherapy for posterior uveal melanomas. Ophthalmology 1984;91:131-136
17. Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 1980;87:582-590
18. Garretson BR, Robertson DM, Earle JD. Choroidal melanoma treatment with iodine-125 brachytherapy. Arch Ophthalmol 1987;105:1394-1397
19. Augsberger JJ, Gamel JW, Lawritzen K, Brady LW. Cobalt-60 plaque radiotherapy vs. enucleation for posterior uveal melanoma. Am J Ophthalmol 1990;109:585-592
20. Gragoudas ES, Goitein M, Koehler AM. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 1977;83:665-673
21. Gragoudas ES, Goitein M, Verhey L. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980;87:571-581
22. Char DH, Saunders W, Castro JR. Helium ion therapy for choroidal melanoma. Ophthalmology 1983;90:1219-1225
23. Forster MH, Bornfeld N, Shultz U. Complications of local beta irradiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmol 1986;224:336-340
24. Guyer DR, Mukai S, Egan KM. Radiation maculopathy after proton beam irradiation for choroidal melanomas. Ophthalmology 1992;99:1278-1285
25. Gragoudas ES, Seddon JM, Egan K. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-353
26. Kim MK, Char DH, Castro JR. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology 1986;93:189-193
27. Rotman M, Long RS, Packer S. Radiation therapy of choroidal melanoma. Trans Ophthalmol Soc UK 1977;97:431-435
28. Lincoff H, McLean J, Long R. The cryosurgical treatment of intraocular tumors. Am J Ophthalmol 1967;63:389-399
29. Davidorf FH, Newman GH, Havener WH, Makley TA Jr. Conservative management of malignant melanoma: II. Trans-scleral diathermy as a method of treatment for malignant melanoma. Arch Ophthalmol 1970;83:273-280
30. Shields JA, Shields CL, Shah P, Sivalingam V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology 1991;98:971-983
31. Damato BE, Foulds WS. Surgical resection of uveal melanomas. In: Ryan S, ed. Retina. St Louis: Mosby, 1994:795-807
32. Peyman GA, Raichand M. Full-thickness eye wall resection of choroidal neoplasms. Ophthalmology 1979;86:1024-1036
33. Coleman DJ, Silverman RH, Iwamoto T. Histopathological effects of ultrasonically induced hyperthermia in intraocular malignant melanoma. Ophthalmology 1988;95: 970-981
34. Journee-de-Korver HG, Vei-burg-van der Marel EH, Oosterhuis JA, et al. Tumoricidal effect of hyperthermia by near infrared irradiation on pigmented hamster melanoma. Lasers Light Ophthalmol 1992;4:175-180
35. Oosterhuis JA, Journee-de-Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanoma. Arch Ophthalmol 1995;113:315-321
36. Riedel KG, Svitra PP, Seddon JM, et al. Proton beam irradiation and hyperthermia. Effects on experimental choroidal melanoma. Arch Ophthalmol 1985;103:1862-1869
37. Meyer-Schwickerath G, Vogel M. Treatment of malignant melanomas of the choroid by photocoagulation. Trans Ophthalmol Soc UK 1977;97:416-420
38. Augsburger JJ, Mullen D, Kleineidan M. Planned combined 1-125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal melanoma. Ophthalmic Surg 1993;24:76-81
39. Shields JA. The expanding role of laser photocoagulation for intraocular tumors: the 1993 H. Christian Zweng memorial lecture. Retina 1994;14:310-322
40. Gragoudas ES, Egan KM, Seddon JM, et al. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99:760-766
41. Weishaupt K, Gomer CJ, Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photoactivation of a murine tumor. Cancer Res 1976;36:2326-2329
42. Gomer CJ, Rucker N, Ferrario A. Properties and applications of photodynamic therapy. Radiat Res 1989;120:1-18
43. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157
44. vanGeel IP, Oppelaar H, Oussoren YG, Stewart FA. Changes in perfusion of mouse tumours after photodynamic therapy. Int J Cancer 1994;56:224-228
45. Nelson JS, Liaw LH, Orenstein A. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin and phthalocyanine. J Natl Cancer Inst 1988;80:1599-1605
46. Castellani A, Pace GP, Concioli M. Photodynamic effect of hematoporphyrin on blood microcirculation. J Pathol Bacteriol 1963;86:99-102
47. 2 from cells by photodynamic treatment. Cancer Res 1989;49:6896-6900
48. Richter AM, Jain AK, Canaan AJ, et al. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A. Biochem Pharmacol 1992;43: 2349-2358
49. Levy JG, Waterfield E, Richter A. Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A. Proc Soc Photo Optical Instr Eng 1994;2078:91-101
50. Gomer CJ, Dougherty TJ. Determination of 3H and 14C hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979;39:146-151
51. Jori G, Tomio L, Reddi E. Preferential delivery of liposome-incorporated porphyrin to neoplastic cells in tumour-bearing rats. Br J Cancer 1983;48:307-309
52. Gal D, McDonald PC, Porter JC. Cholesterol metabolism in cancer cells in monolayer culture: III. Low density lipoprotein metabolism. Int J Cancer 1981;28:315-319
53. Allison BA, Waterfield E, Richter AM, Levy LG. The effect of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol 1991;54:709-715
54. Richter AM, Waterfield E, Jain AK, et al. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 1993;57:1000-1006
55. McCaughan JS Jr, Guy JT, Hicks W, et al. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 1989;124:211-216
56. Wilson BD, Mang TS, Stoll H, et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992;128:1597-1601
57. Okunaka T, Kato H, Konaka C, et al. Photodynamic therapy for multiple primary bronchogenic carcinoma. Cancer 1991;68:253-258
58. McCaughan JS Jr, Hawley PC, Bethel BH, Walker J. Photodynamic therapy of endobronchial malignancies. Cancer 1988;62:691-701
59. Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 1995;109:63-72
60. Prout GR Jr, Lin CW, Benson R Jr. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 1987;317:1251-1255
61. Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors. Semin Surg Oncol 1995;11:335-345
62. Marcus SL. Current status of photodynamic therapy for human cancer. Proc Soc Photo Optical Instr Eng 1991;1426:302-310
63. Davis RK. Photodynamic therapy in head and neck cancer. Adv Otorhinolaryngol 1995; 49:58-62
64. Tse DT, Dutton JJ, Weingeist TA. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol 1984;102:833-838
65. Bruce RA Jr. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanoma. Lasers Surg Med 1984;4:59-64
66. Murphree A, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol 1987;46:919-923
67. Favilla I, Barry WR, Gosbell A. Phototherapy of posterior uveal melanomas. Br J Ophthalmol 1991;75:718-721
68. Ozler SA, Nelson S, Liggett PE, et al. Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol 1992;110:555-561
69. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 1994;101:89-99
70. Hill RA, Reddi S, Kenney ME. Photodynamic therapy of ocular melanoma with bis silicon 2,3-naphthalocyanine in a rabbit model. Invest Ophthalmol Vis Sci 1995;36: 2476-2481
71. Panagopoulas JA, Svitra PP, Puliafito CA, Gragoudas ES. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol 1989;107:886-890
72. Hu LK, Huh K, Gragoudas ES, Young LHY. Establishment of pigmented choroidal melanomas in a rabbit model. Retina 1994;14:264-269
73. Gonzalez VH, Hu LK, Theodossiadis PG, et al. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci 1995;36:871-878
74. Young LHY, Howard MA, Hu LK, Gragoudas ES. Photodynamic therapy of pigmented choroidal melanoma using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol 1996;114:186-192
75. Kim RY, Hu LK, Foster BS, et al. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996;103:2029-2036
76. Hu LK, Hasan T, Gragoudas ES, Young LHY. Photoimmunotherapy of human melanoma cells. Exp Eye Res 1995;61:385-391
77. Jiang FN, Liu DJ, Neyndorff H, et al. Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate. J Natl Cancer Inst 1991;83:1218-1225
78. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol 1992;55:931-948
79. Mang TS, Dougherty TJ. Time and sequence dependent influence of in vivo photodynamic therapy survival by hyperthermia. Photochem Photobiol 1985;42:533-540
80. Waldow SM, Henderson BW, Dougherty TJ. Potentiation of photodynamic therapy by heat: effect of sequence and time interval between treatments in vivo. Lasers Surg Med 1985;5:83-94
81. Frietas I, Pontiggia P, Barronzio GF, McLaren JR. Perspectives for the combined use of photodynamic therapy and hyperthermia in cancer patients. Adv Exp Med Biol 1990; 267:511-520
82. Zhao FY, Zhang KH, Huang KH, et al. Use of hematoporphyrin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumors: a preliminary report. Lasers Med Sci 1986;1:253-256
83. Graschew G, Shopova M. Photodynamic therapy and gamma-irradiation: effect of tumor-cell reoxygenation. Lasers Med Sci 1986;1:193-195
84. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985;45:1608-1610
85. Jirsa M, Pouckova P, Dolezal J, et al. Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. Eur J Cancer 1991;27:109
86. Bown SG. Photodynamic therapy to scientists and clinicians - one world or two? Photochem Photohiol 1990;6:1-12